TG Therapeutics Dividend
What is TG Therapeutics's current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage
Dividend Yield vs Market
| TG Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (TGTX) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Biotechs) | 2.5% |
| Analyst forecast in 3 Years (TGTX) | 0% |
Notable Dividend: Unable to evaluate TGTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TGTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
| Month | Dividend Per Share (annual) | Avg. Yield (%) |
|---|---|---|
| 12/31/2023 | - | 1 |
Stable Dividend: Insufficient data to determine if TGTX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TGTX's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as TGTX has not reported any payouts.